Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

2.

Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.

Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE.

Science. 1999 Sep 17;285(5435):1920-3.

4.
5.

Interleukin-1.

Dinarello CA.

Cytokine Growth Factor Rev. 1997 Dec;8(4):253-65. Review.

PMID:
9620641
6.

Interleukin-1: basic science and clinical applications.

Patarca R, Fletcher MA.

Crit Rev Oncog. 1997;8(2-3):143-88. Review. No abstract available.

PMID:
9570293
7.
8.

The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.

Cornelis GR, Wolf-Watz H.

Mol Microbiol. 1997 Mar;23(5):861-7. Review.

9.

Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.

Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD.

J Exp Med. 1996 Apr 1;183(4):1427-36.

10.
11.

Yersinia enterocolitica invasin: a primary role in the initiation of infection.

Pepe JC, Miller VL.

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6473-7.

12.

Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis.

Perdomo OJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P, Sansonetti PJ.

J Exp Med. 1994 Oct 1;180(4):1307-19.

13.

Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M.

J Clin Invest. 1995 Aug;96(2):884-92.

14.

Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection.

Pepe JC, Wachtel MR, Wagar E, Miller VL.

Infect Immun. 1995 Dec;63(12):4837-48.

15.

Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity.

Fuhlbrigge RC, Sheehan KC, Schreiber RD, Chaplin DD, Unanue ER.

J Immunol. 1988 Oct 15;141(8):2643-50.

PMID:
3262667
17.
19.

Transition from interleukin 1 beta (IL-1 beta) to IL-1 alpha production during maturation of inflammatory macrophages in vivo.

Beuscher HU, Rausch UP, Otterness IG, Röllinghoff M.

J Exp Med. 1992 Jun 1;175(6):1793-7.

20.

Supplemental Content

Support Center